Taken together, these findings suggest the involvement of SULT1A1 and IS in the progression or deterioration of cisplatin-induced kidney injury via the cisplatin/IS/AhR/ROS axis (summarized in Figure 9). This evidence concerns the gene SULT1A1 and injury.